glp 1 medication microdose FITISH GLP-1 MICRODOSING PROGRAM Microdose GLP-1 | Low-Dose Semaglutide

A small drop of blood at the insertion point is normal

These medications slow gastric emptying and reduce appetite, which means patients often experience changes in their eating patterns, portion sizes, and food preferences

A patient should not have to guess whether a symptom is normal, whether a dose is too high, or whether treatment should be paused

In the second trial, SURPASS-2, tirzepatide administered at doses of 5 mg, 10 mg, or 15 mg showed superior efficacy compared to semaglutide (1 mg) in reducing body weight and HbA1c levels over 40 weeks in patients with T2DM inadequately controlled with metformin [66]

Current data suggest that obesity is a chronic relapsing disease